Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

51 trials with published results (12%)

Research Maturity

245 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.1%

17 terminated out of 419 trials

Success Rate

93.5%

+7.0% vs benchmark

Late-Stage Pipeline

10%

42 trials in Phase 3/4

Results Transparency

21%

51 of 245 completed with results

Key Signals

51 with results94% success17 terminated

Data Visualizations

Phase Distribution

281Total
Not Applicable (226)
Early P 1 (1)
P 1 (3)
P 2 (9)
P 3 (14)
P 4 (28)

Trial Status

Completed245
Unknown80
Recruiting32
Active Not Recruiting19
Terminated17
Not Yet Recruiting12

Trial Success Rate

93.5%

Benchmark: 86.6%

Based on 245 completed trials

Clinical Trials (419)

Showing 20 of 20 trials
NCT07746739Not ApplicableCompleted

Efficacy of Platelet Rich Plasma on Pelvic Floor Muscle Strength and Recurrence Rate in Pelvic Organ Prolapse Surgery

NCT04858438Not ApplicableWithdrawnPrimary

Pain After Insufflation for Robotic Sacrocolpopexy (PAIRS) Trial

NCT05910021Completed

Early Safety of Resection Rectopexy and Sacrocolpopexy

NCT07471464RecruitingPrimary

Centered Surgery - Preoperative Counseling and Patient Satisfaction

NCT07692789Not ApplicableRecruitingPrimary

Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems

NCT06634459Not ApplicableActive Not RecruitingPrimary

POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment

NCT04829058RecruitingPrimary

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

NCT04829175Recruiting

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

NCT05812859Not ApplicableActive Not RecruitingPrimary

Vaginal Orthosis Use After Vaginal Reconstructive Surgery

NCT05731284Not ApplicableActive Not RecruitingPrimary

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

NCT01095692Not ApplicableTerminated

Evaluating the Necessity of TOT Implantation in Women With Pelvic Organ Prolapse and Occult Stress Urinary Incontinence

NCT02890498CompletedPrimary

Vaginal Microbiota as a Decisive Factor in Vaginal Prosthetic Surgery

NCT02800512Not ApplicableTerminatedPrimary

SCP vs HUSLS for Pelvic Organ Prolapse Repair

NCT06532292Not ApplicableCompletedPrimary

Physical Therapy Intervention for Pelvic Organ Prolapses

NCT07517965Not ApplicableRecruitingPrimary

Vaginal Vault Native Tissue Suspension

NCT07554651Not ApplicableCompletedPrimary

Cross-Shaped Vaginal Pessary for Pelvic Organ Prolapse

NCT02965313Not ApplicableActive Not RecruitingPrimary

Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial

NCT07552337Not ApplicableCompletedPrimary

Unilateral Versus Bilateral High Uterosacral Ligament Suspension Following vNOTES Hysterectomy for Apical Pelvic Organ Prolapse: A Prospective Study

NCT07218016Not ApplicableRecruitingPrimary

Accelerometer Measured Early Recovery After Prolapse Surgery

NCT04179955Active Not RecruitingPrimary

Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse

Scroll to load more

Research Network

Activity Timeline